Management of complications and sequelae with temporary injectable fillers

Plastic and Reconstructive Surgery

Volumn 120, Issue 6 S SUPPL., 2007, Pages

  Alam, Murad ^a   Dover, Jeffrey S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FILLER; HYALURONIC ACID; HYDROXYAPATITE; LIDOCAINE; LMX; POLYLACTIC ACID; TACROLIMUS; UNCLASSIFIED DRUG;

ARTERY THROMBOSIS; CRYOTHERAPY; ECCHYMOSIS; HUMAN; IMPLANT; INJECTION SITE DISCOMFORT; INJECTION SITE HYPERSENSITIVITY; INJECTION SITE NECROSIS; INJECTION SITE REACTION; INJECTION SITE SWELLING; MEDLINE; PRIORITY JOURNAL; RETINA ARTERY OCCLUSION; REVIEW; SAFETY; VASCULAR DISEASE;

DERMATOLOGIC AGENTS; DRUG HYPERSENSITIVITY; ECCHYMOSIS; FACE; HUMANS; INJECTIONS, INTRADERMAL; NECROSIS; TIME FACTORS;

EID: 37349008929     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000248859.14788.60     Document Type: Review

References (25)

1. Alam, M., Dover, J. S., Solish, N., and Arndt, K. A. Safety and persistence of injectable augmentation materials for correction of facial rhytids. J. Am. Acad. Dermatol. (in press).
2. Andre, P., Lowe, N. J., Parc, A., Clerici, T. H., and Zimmermann, U. Adverse reactions to dermal fillers: A review of European experiences. J. Cosmet. Laser Ther. 7: 171, 2005.
3. Lowe, N. J., Maxwell, C. A., and Patnaik, R. Adverse reactions to dermal fillers: Review. Dermatol. Surg. 31: 1616, 2005.
4. Duffy, D. M. Complications of fillers: Overview. Dermatol. Surg. 31: 1626, 2005.
5. Dover, J. S., Carruthers, A., Carruthers, J., and Alam, M. Clinical use of Restylane. Skin Ther. Lett. 10: 5, 2005.
6. Glaich, A. S., Cohen, J. L., and Goldberg, L. H. Injection necrosis of the glabella: Protocol for prevention and treatment after use of dermal fillers. Dermatol. Surg. 32: 276, 2006.
7. Hirsch, R. J., Narurkar, V., and Carruthers, J. Management of injected hyaluronic acid induced Tyndall effects. Lasers Surg. Med. 38: 202, 2006.
8. Lupton, J. R., and Alster, T. S. Cutaneous hypersensitivity reaction to injectable hyaluronic acid gel. Dermatol. Surg. 26: 135, 2000.
9. Shafir, R., Amir, A., and Gur, E. Long-term complications of facial injections with Restylane (injectable hyaluronic acid). Plast. Reconstr. Surg. 106: 1215, 2000.
10. Fernandez-Acenero, M. J., Zamora, E., and Borbujo, J. Granulomatous foreign body reaction against hyaluronic acid: Report of a case after lip augmentation. Dermatol. Surg. 29: 1225, 2003.
11. Raulin, C., Greve, B., Hartschuh, W., and Soegding, K. Exudative granulomatous reaction to hyaluronic acid (Hylaform). Contact Derm. 43: 178, 2000.
12. Sidwell, R. U., Dhillon, A. P., Butler, P. E., and Rustin, M. H. Localized granulomatous reaction to a semi-permanent hyaluronic acid and acrylic hydrogel cosmetic filler. Clin. Exp. Dermatol. 29: 630, 2004.
13. Matarasso, S. L., and Herwick, R. Hypersensitivity reaction to nonanimal stabilized hyaluronic acid. J. Am. Acad. Dermatol. 55: 128, 2006.
14. Lowe, N., Maxwell, C. A., Lowe, P., Duick, M. G., and Shar, K. Hyaluronic acid skin fillers: Adverse reactions and skin testing. J. Am. Acad. Dermatol. 45: 930, 2001.
15. Lerner, H. Sculptra-P030050. Presented at the General and Plastic Surgery Devices Advisory Panel. Division of General, Restorative and Neurological Devices, Plastic and Reconstructive Surgical Devices, U.S. Food and Drug Administration, March 25, 2004.
16. Forbes-McKean, K., and Handler, J. A. Sculptra (injectable poly-L-lactic acid) PMA P030050. Presentation to the General and Plastic Surgery Devices Advisory Panel. Dermik Laboratories, March 25, 2004.
17. Collins, S., Levin, J., and Lerner, H. FDA panel recommends approval of New-Fill. H.I.V. Treat. Bull. 5: 2004.
18. Valantin, M.-A., Aubron-Olivier, C., Ghosn, J., et al. Polylactic acid implants: Results of the open-label study VEGA. AIDS 17: 2471, 2003.
19. Meszaros, L. Collagen alternatives for facial soft-tissue augmentation offers good results. Cosmet. Surg. Times July: 2003.
20. Reisberger, E.-M., Landthaler, M., Wiest, L., Schroder, J., and Stolz, W. Foreign body granulomas caused by polymethylmethacrylate microspheres. Arch. Dermatol. 139: 17, 2003.
21. Soparkar, C. N., Patrinely, J. R., and Tschen, J. Erasing restylane. Ophthal. Plast. Reconstr. Surg. 20: 317, 2004.
22. Lambros, V. The use of hyaluronidase to reverse the effects of hyaluronic acid filler. Plast. Reconstr. Surg. 114: 277, 2004.
23. Parada, M. B., Michalany, N. S., Hassun, K. M., Bagatin, E., and Talarico, S. A histologic study of adverse effects of different cosmetic skin fillers. Skinmed 4: 345, 2005.
24. Inamed Corporation. CosmoDerm/CosmoPlast Collagen Replacement Therapy (condensed package insert). In CosmoDerm and CosmoPlast: Replacing Natural Collagen (patient brochure). Santa Barbara, Calif.: Inamed Aesthetics, Inamed Corporation, 2003.
25. Alam, M., Levy, R., Pavjani, U., et al. Safety of radiofrequency treatment over human skin previously injected with medium-term injectable soft-tissue augmentation materials: A controlled pilot trial. Lasers Surg. Med. 38: 205, 2006.